KL and diabetic kidney disease: The clinical implication is that if exogenous Klotho supplementation or endogenous Klotho expression can be promoted in the early stage of diabetes, it is expected to protect podocytes before the occurrence of proteinuria, thereby delaying or even blocking the occurrence of DKD.